SCHEMBL7315402

SCHEMBL7315402

COC(=O)c1c(Cc2ccc(Br)cc2)c(C)c(N)c(C)c1S(=O)(=O)c1ccc(OC)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.45
ERBB2 P04626 1/20 0.45
GRK2 P25098 1/20 0.42
MMP1 P03956 4/20 0.42
MMP9 P14780 4/20 0.42
MMP13 P45452 4/20 0.42
MMP2 P08253 3/20 0.42
MMP3 P08254 3/20 0.42
MMP8 P22894 3/20 0.42
MMP12 P39900 3/20 0.42
MMP14 P50281 3/20 0.42
MMP16 P51512 3/20 0.42
ADAM17 P78536 2/20 0.42
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 2/20 0.41
FPR2 P25090 2/20 0.40
FPR1 P21462 1/20 0.40
THRB P10828 2/20 0.39
TP53 P04637 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7323949 0.91 EGFR (0.44) EGFRERBB2GRK2MMP1MMP9
SCHEMBL7317410 0.90 ALDH1A1 (0.47) MMP1MMP9MMP13MMP2MMP3
SCHEMBL7311138 0.89 MMP13 (0.39) EGFRERBB2MMP1MMP9MMP13
SCHEMBL7313804 0.85 ALDH1A1 (0.45) MMP1MMP9MMP13MMP2MMP3
SCHEMBL7314232 0.85 MMP2 (0.48) MMP1MMP9MMP13MMP2MMP3
SCHEMBL7324368 0.85 CA1 (0.42) MMP1MMP9MMP13MMP2MMP3
SCHEMBL7323152 0.85 EGFR (0.43) EGFRERBB2GRK2MMP1MMP9
SCHEMBL7317696 0.84 LMNA (0.42) MMP1MMP9MMP13MMP2MMP3
SCHEMBL7323459 0.83 LMNA (0.41) MMP1MMP9MMP13MMP2MMP3
SCHEMBL7324058 0.83 NAMPT (0.49) MMP1MMP9MMP13ADAM17ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5929097-A INHIBIT TUMOR NECROSIS FACTOR-ALPHA CONVERTING ENZYME AMERICAN CYANAMID COMPANY (US) 1999-07-27 US disclosed